Interestingly, the differences described above were particularly prominent when comparing ALD-MAFLD vs. ALD-without MAFLD with lower serum total bilirubin (27 vs. 41 μmol/L, p = 0.002), higher albumin (29 vs. 27 g/L, p = 0.003) and lower MELD (12 vs. 13, p = 0.020) suggesting better liver function in patients with ALD-HCC and MAFLD. The gene discussed is ALB; the disease is hepatocellular carcinoma.